Idiopathic Pulmonary Fibrosis

Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p
Julien Guiot, Maureen Cambier, Amandine Boeckx, Monique Henket, Olivier Nivelles, Fanny Gester, Edouard Louis, Michel Malaise, Franck Dequiedt, Renaud Louis, Ingrid Struman, Makon-Sébastien Njock

Thorax Aug 2020, thoraxjnl-2019-214077; DOI: 10.1136/thoraxjnl-2019-214077
Unraveling the role of MUC5B in idiopathic interstitial pneumonias (IIPs)
Evgenia Dobrinskikh, Ivana V Yang

Thorax Aug 2020, thoraxjnl-2020-215406; DOI: 10.1136/thoraxjnl-2020-215406
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects
Catherine Overed-Sayer, Elena Miranda, Rebecca Dunmore, Elena Liarte Marin, Lorea Beloki, Doris Rassl, Helen Parfrey, Alan Carruthers, Amina Chahboub, Sofia Koch, Gülin Güler-Gane, Michael Kuziora, Arthur Lewis, Lynne Murray, Richard May, Deborah Clarke

Thorax Jul 2020, thoraxjnl-2019-214000; DOI: 10.1136/thoraxjnl-2019-214000
Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome
Joseph Jacob, Leon Aksman, Nesrin Mogulkoc, Alex J Procter, Bahareh Gholipour, Gary Cross, Joseph Barnett, Christopher J Brereton, Mark G Jones, Coline H van Moorsel, Wouter van Es, Frouke van Beek, Marcel Veltkamp, Sujal R Desai, Eoin Judge, Teresa Burd, Maria Kokosi, Recep Savas, Selen Bayraktaroglu, Andre Altmann, Athol U Wells

Thorax Aug 2020, 75 (8) 648-654; DOI: 10.1136/thoraxjnl-2019-213865
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case–control study
Michael J Abramson, Tsitsi Murambadoro, Sheikh M Alif, Geza P Benke, Shyamali C Dharmage, Ian Glaspole, Peter Hopkins, Ryan F Hoy, Sonja Klebe, Yuben Moodley, Shuli Rawson, Paul N Reynolds, Rory Wolfe, Tamera J Corte, E Haydn Walters

Thorax Jul 2020, thoraxjnl-2019-214478; DOI: 10.1136/thoraxjnl-2019-214478
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?
Carmel J Stock, Caterina Conti, Ángeles Montero-Fernandez, Gaetano Caramori, Philip L Molyneaux, Peter M George, Maria Kokosi, Vaslis Kouranos, Toby M Maher, Felix Chua, Alexandra Rice, Christopher P Denton, Andrew G Nicholson, Athol Wells, Piersante Sestini, Elisabetta A Renzoni

Thorax Jun 2020, thoraxjnl-2020-214579; DOI: 10.1136/thoraxjnl-2020-214579
Gender in idiopathic pulmonary fibrosis diagnosis: time to address unconscious bias
Mary E Strek

Thorax May 2020, 75 (5) 365-366; DOI: 10.1136/thoraxjnl-2020-214569
Patient gender bias on the diagnosis of idiopathic pulmonary fibrosis
Deborah Assayag, Julie Morisset, Kerri A Johannson, Athol U Wells, Simon L F Walsh

Thorax May 2020, 75 (5) 407-412; DOI: 10.1136/thoraxjnl-2019-213968
Is the microbiome-induced glycolytic pathway a harbinger of acute exacerbation of idiopathic pulmonary fibrosis?
Ram P Naikawadi

Thorax Mar 2020, 75 (3) 200-201; DOI: 10.1136/thoraxjnl-2019-214374
GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation
Soo Jung Cho, Jong-Seok Moon, Kiichi Nikahira, Ha Seon Yun, Rebecca Harris, Kyung Sook Hong, Huarong Huang, Augustine M K Choi, Heather Stout-Delgado

Thorax Mar 2020, 75 (3) 227-236; DOI: 10.1136/thoraxjnl-2019-213571

Main menu

Idiopathic Pulmonary Fibrosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Idiopathic Pulmonary Fibrosis

Pages